Quick Scale-Up Services

Quick Scale-Up Services (Non-GMP/GMP) in Early Drug Discovery

Zasya offers Quick Scale-Up Services are designed to efficiently transition your compounds from laboratory-scale synthesis to larger quantities required for preclinical and clinical development, to both non-GMP and GMP standards.

Zasya’s Approach to Quick Scale-Up (Non-GMP/GMP)

Non-GMP Scale-Up for Early Development

1st_icon

Process Evaluation

We conduct thorough assessments of synthetic routes to identify the most efficient and scalable pathways for your compounds.

2nd_icon

Optimization

Utilizing principles of Quality by Design (QbD), we refine processes to enhance yield, purity, and overall robustness.

3rd_icon

Demonstration Batches

Execution of non-GMP batches to validate scalability and identify potential challenges prior to GMP production.

Quality Control

Preclinical Supply

Timely provision of high-quality material to support toxicology studies and other preclinical evaluations.

GMP Scale-Up for Clinical Readiness

drug discovery

Process Transfer

Seamless transition from non-GMP to GMP-compliant processes, ensuring consistency and reliability.

Accurate Results

Regulatory Alignment

Adherence to cGMP to meet regulatory expectations for clinical trial materials.

Stability studies-1

Batch Production

Manufacture of clinical trial materials with rigorous quality control to ensure safety and efficacy.

Advanced Instrumentation

Analytical Support

Comprehensive testing and validation to confirm that all materials meet predefined specifications

image

Why Partnering with Zasya for quick scale up

End to End support

Expert team

Let’s bring your discoveries to life—faster, smarter, and with unmatched precision with Zasya